Boardroom Alpha
Start trial
8-K primary document
CHPT · Current Report (Form 8-K) · Filed June 30, 2026

Chargepoint Holdings Inc — 8-K exhibit

chpt-firstamendmenttowilme.htm
Chargepoint Holdings Inc on Boardroom Alpha
Document
Exhibit 10.1
CHARGEPOINT HOLDINGS, INC.

FIRST AMENDMENT TO
SEVERANCE AND CHANGE IN CONTROL AGREEMENT

 
This FIRST AMENDMENT TO THE SEVERANCE AND CHANGE IN CONTROL AGREEMENT (this “Amendment”) by and between ChargePoint Holdings, Inc., a Delaware corporation (the “Company”), and Rick Wilmer (the “Executive”) is entered into and made effective as of June 29, 2026 (the “Amendment Date”). 
WITNESSETH
WHEREAS, the Company and Executive entered into that certain Severance and Change in Control Agreement, dated November 15, 2023 (the “Severance Agreement”); and
WHEREAS, the Company and Executive now wish to amend the Severance Agreement as provided herein, effective as of the Amendment Date.
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and the terms and conditions set forth below, the Company and Executive hereby agree as follows:
1.Section 1 of the Severance Agreement is amended in its entirety to read as follows:
Term. This Agreement shall continue until Executive’s Separation. Termination of this Agreement shall not affect any rights or obligations of any party that have accrued or become vested prior to such Separation.
2.This Amendment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
3.This Amendment, including the validity, interpretation, construction and performance of this Amendment, shall be governed by and construed in accordance with the laws of the State of California applicable to agreements made and to be performed in such State, without regard to such State’s conflicts of law principles.
4.Except as provided herein, all provisions of the Severance Agreement are and shall remain in full force and effect and are hereby ratified and confirmed in all respects and the execution, delivery, and effectiveness of this Amendment shall not operate as a waiver or amendment of any provision of the Severance Agreement not specifically amended or supplemented.
Signatures on the Following Page
1




SIGNATURE PAGE TO FIRST AMENDMENT TO SEVERANCE AND CHANGE IN CONTROL AGREEMENT
 
In Witness Whereof, the parties have executed this Amendment as of the date first written above.
 
CHARGEPOINT HOLDINGS, INC.
 
 
By:_/s/ Bruce Chizen______________________
Name: Bruce Chizen
Title: Chairman of the Board
 

EXECUTIVE


_/s/Rick Wilmer_____________________
Rick Wilmer
 
 

2

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer